310 related articles for article (PubMed ID: 1333465)
21. Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone.
Rumsby PC; Davies MJ; Evans JG
Mol Carcinog; 1994 Feb; 9(2):71-5. PubMed ID: 8142011
[TBL] [Abstract][Full Text] [Related]
22. The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing.
Kurvinen K; Tervahauta A; Syrjänen S; Chang F; Syrjänen K
Anticancer Res; 1994; 14(1A):177-81. PubMed ID: 8166446
[TBL] [Abstract][Full Text] [Related]
23. Effect of non-tumor cell contamination on detection of p53 gene mutations in human gastric cancer cells by polymerase chain reaction single-strand conformation polymorphism analysis.
Hong WS; Hong SI; Lee DS; Son Y
Korean J Intern Med; 1994 Jan; 9(1):20-4. PubMed ID: 8038143
[TBL] [Abstract][Full Text] [Related]
24. p53 mutations in human bladder cancer.
Kusser WC; Miao X; Glickman BW; Friedland JM; Rothman N; Hemstreet GP; Mellot J; Swan DC; Schulte PA; Hayes RB
Environ Mol Mutagen; 1994; 24(3):156-60. PubMed ID: 7957118
[TBL] [Abstract][Full Text] [Related]
25. Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?
Yamada R; Maeda N; Oguri H; Adachi Y; Takeuchi T; Furihata M; Fukaya T
Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):96-100. PubMed ID: 24017961
[TBL] [Abstract][Full Text] [Related]
26. Detection of DNA aberrations in human cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products.
Murakami Y; Suzuki Y; Kishimoto Y; Hirohashi S; Hayashi K; Sekiya T
Tohoku J Exp Med; 1992 Oct; 168(2):247-55. PubMed ID: 1339101
[TBL] [Abstract][Full Text] [Related]
27. Detection of mutations in the p53 gene in human head and neck carcinomas by single strand conformation polymorphism analysis.
Chang YS; Lin YJ; Tsai CN; Shu CH; Tsai MS; Choo KB; Liu ST
Cancer Lett; 1992 Dec; 67(2-3):167-74. PubMed ID: 1336431
[TBL] [Abstract][Full Text] [Related]
28. Rapid and effective detection of mutations in the p53 gene using nonradioactive single-strand conformation polymorphism (SSCP) technique applied on PhastSystem.
Kurvinen K; Hietanen S; Syrjänen K; Syrjänen S
J Virol Methods; 1995 Jan; 51(1):43-53. PubMed ID: 7730436
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the p53 gene in human astrocytomas: detection by single-strand conformation polymorphism analysis and direct DNA sequencing.
Hunter SB; Bandea C; Swan D; Abbott K; Varma VA
Mod Pathol; 1993 Jul; 6(4):442-5. PubMed ID: 8415589
[TBL] [Abstract][Full Text] [Related]
30. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry.
Koga H; Zhang S; Kumanishi T; Washiyama K; Ichikawa T; Tanaka R; Mukawa J
Acta Neuropathol; 1994; 87(3):225-32. PubMed ID: 8009954
[TBL] [Abstract][Full Text] [Related]
31. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.
Okamoto A; Sameshima Y; Yokoyama S; Terashima Y; Sugimura T; Terada M; Yokota J
Cancer Res; 1991 Oct; 51(19):5171-6. PubMed ID: 1680546
[TBL] [Abstract][Full Text] [Related]
32. Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas.
Noguchi M; Maezawa N; Nakanishi Y; Matsuno Y; Shimosato Y; Hirohashi S
Diagn Mol Pathol; 1993 Mar; 2(1):29-35. PubMed ID: 8287223
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of p53 gene alterations in node-negative breast cancer.
Elledge RM; Fuqua SA; Clark GM; Pujol P; Allred DC; McGuire WL
Breast Cancer Res Treat; 1993; 26(3):225-35. PubMed ID: 8251647
[TBL] [Abstract][Full Text] [Related]
34. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis.
Tamura G; Kihana T; Nomura K; Terada M; Sugimura T; Hirohashi S
Cancer Res; 1991 Jun; 51(11):3056-8. PubMed ID: 2032245
[TBL] [Abstract][Full Text] [Related]
35. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer.
Kohler MF; Marks JR; Wiseman RW; Jacobs IJ; Davidoff AM; Clarke-Pearson DL; Soper JT; Bast RC; Berchuck A
J Natl Cancer Inst; 1993 Sep; 85(18):1513-9. PubMed ID: 8360934
[TBL] [Abstract][Full Text] [Related]
36. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
[TBL] [Abstract][Full Text] [Related]
37. p53 expression, mutation, and allelic deletion in ovarian cancer.
McManus DT; Yap EP; Maxwell P; Russell SE; Toner PG; McGee JO
J Pathol; 1994 Nov; 174(3):159-68. PubMed ID: 7823248
[TBL] [Abstract][Full Text] [Related]
38. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR
Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850
[TBL] [Abstract][Full Text] [Related]
39. F-SSCP: fluorescence-based polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis.
Makino R; Yazyu H; Kishimoto Y; Sekiya T; Hayashi K
PCR Methods Appl; 1992 Aug; 2(1):10-3. PubMed ID: 1490170
[TBL] [Abstract][Full Text] [Related]
40. Identification of p53 mutations in endometrial adenocarcinoma by polymerase chain reaction-single-strand conformation polymorphism.
Wachtel SS; Wachtel G; Shulman LP; Phillips O; Miller B; Photopulos G
J Soc Gynecol Investig; 1994; 1(3):234-7. PubMed ID: 9419777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
